About
Senseye develops surface plasmon resonance (SPR) sensor technology for advanced diagnostics and research, including high-sensitivity sensors for detecting antibody binding to SARS-CoV-2 variants.
Explore Senseye's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.